The prognostic value of circulating tumor DNA in malignant melanoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

The prognostic value of circulating tumor DNA in malignant melanoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

BackgroundCirculating tumor DNA (ctDNA) is an emerging biomarker in malignant melanoma(MM), and high levels of ctDNA may reflect a higher tumor load. However, its prognostic value for MM receiving immune checkpoint inhibitors(ICI) remains controversial. This meta-analysis aimed to elucidate the prog...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lei Liu, Shufu Hou, Aiping Zhu, Bing Yan, Linchuan Li, Dandan Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	circulating tumor DNA immune checkpoint inhibitors malignant melanoma overall survival progression-free survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1520441/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ocular adnexal lymphoma – A single-center observational study of survival outcomes
by: Karuvel Kannan Saraswathi, et al.
Published: (2025-02-01)

Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis
by: Nilesh Kodali, et al.
Published: (2024-09-01)

Primary malignant melanoma of the lung; a case report and literature review
by: Yub Raj Sedhai, et al.
Published: (2025-01-01)

Primary intracranial malignant melanoma in an adolescent: case report and literature review
by: Nyoman Golden, et al.
Published: (2025-02-01)

The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study
by: Keiichiro Suminaga, et al.
Published: (2025-02-01)

Evaluating the surgical and oncological outcomes of hepatic artery variations in minimally invasive pancreaticoduodenectomy: insights from 2023 data at a high-volume pancreatic center
by: Tianyu Li, et al.
Published: (2025-02-01)

Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy
by: Yiwen Qiu, et al.
Published: (2025-02-01)

Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study
by: Chenming Liu, et al.
Published: (2025-02-01)

Multiparameter body composition analysis on chest CT predicts clinical outcomes in resectable non-small cell lung cancer
by: Yilong Huang, et al.
Published: (2025-02-01)

Tumor characteristics and survival rate of axillary metastatic breast cancer patients: a three decades retrospective cohort study
by: Seyed Mohamad Sadegh Mousavi-kiasary, et al.
Published: (2025-02-01)

Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification
by: Youngkyung Jeon, et al.
Published: (2024-01-01)

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
by: Hilin Yildirim, et al.
Published: (2025-02-01)

Outcomes after Surgery for Malignant Pancreatic Neuroendocrine Tumors
by: Omar Hama Ghalib Azeez Hawramy, et al.
Published: (2019-08-01)

Effect of “Time To Surgery” on the Endometrial Cancer Prognosis
by: Engin Celik, et al.
Published: (2022-03-01)

Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
by: Yin-Che Wang, et al.
Published: (2025-12-01)

Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
by: Maria Elena Lacruz, et al.
Published: (2025-02-01)

Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study
by: Yaqin Dong, et al.
Published: (2025-02-01)

Dynamic monocyte changes as prognostic indicators in operable gastric cancer: a retrospective cohort analysis
by: Yiwei Jiang, et al.
Published: (2025-02-01)

Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
by: Sumaira Siddiqui
Published: (2024-04-01)

Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
by: Shuta Ohara, MD, PhD, et al.
Published: (2025-03-01)

Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations
by: Sophia Kreft, et al.
Published: (2025-01-01)

Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer
by: Linna Gao, et al.
Published: (2025-02-01)

Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
by: Mengdi Fu, et al.
Published: (2025-02-01)

18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma
by: Tine Gadegaard Hindso, et al.
Published: (2025-02-01)

Long term effectiveness of intraoperative radiotherapy given as a boost in adjuvant treatment for oral cavity cancers
by: Grzegorz Woźniak, et al.
Published: (2025-02-01)

Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
by: Jieran Long, et al.
Published: (2024-09-01)

The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma
by: Andrew C. Kidd, et al.
Published: (2024-01-01)

Unusual Cause of Diffuse Pleural Thickening (Malignant Pleural Mesothelioma Mimic): Undifferentiated Epithelioid Malignant Neoplasm
by: Jamal Al-Aghbari, et al.
Published: (2024-07-01)

Comprehensive landscape and oncogenic role of extrachromosomal circular DNA in malignant biliary strictures
by: Zhuo Cheng, et al.
Published: (2025-02-01)

Analysis of clinical and pathological prognostic factors of survival in rectal adenocarcinoma treated with preoperative radiochemotherapy
by: Sarhan Sydney Saad, et al.
Published: (2025-02-01)

Comparison of Survival Outcomes of Lymphovascular Space Invasion-Negative and Lymphovascular Space Invasion - Positive Women with Stage IIIC Endometrioid Endometrial Cancer: A Case - Control Study
by: Zeliha Firat Cuylan, et al.
Published: (2021-04-01)

Comparative effectiveness of laparoscopic versus open colectomy in colon cancer patients: a study protocol for emulating a target trial using cancer registry data
by: Semaw Ferede Abera, et al.
Published: (2025-01-01)

Impact of positive CD4 cells on event‐free survival in follicular lymphoma patients
by: Cong Li, et al.
Published: (2024-09-01)

Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
by: Xudong Zhang, et al.
Published: (2024-09-01)

Defining the high-risk category of patients with cutaneous melanoma: a practical tool based on prognostic modeling
by: Oleksandr Dudin, et al.
Published: (2025-02-01)

Construction and validation of a prognostic model for NK/T-cell lymphoma based on random survival forest algorithm
by: HUANG Zhen, et al.
Published: (2025-02-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Acral Lentiginous Melanoma Presenting with Amelanotic Metastasis
by: Alaka J Mohan, et al.
Published: (2025-01-01)

Pulmonary Nuclear protein in Testis (NUT) carcinoma: clinical, molecular characteristics, and treatment strategies
by: Jingjing Qu, et al.
Published: (2025-02-01)

The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01)